Did you know that the market for prebiotics is expected to increase by 11.3% per year until 2030? Health-conscious customers, as well as new applications in the feed industry are driving demand. With acib’s expertise on prebiotic bioproduction, companies can confidently venture into this lucrative market. Seize this opportunity!
Background
Technology
acib has developed many industrial biocatalysts and has used them in biocatalytic processes for the production of various prebiotics. With the right expertise on enzyme expression, engineering, immobilization and biocatalyst formulation, reaction engineering and subsequent process design including integrated downstream processing, we can report on several successful case studies:
Offer
acib offers to provide functional prebiotics in quantities suitable for testing, with options available in the kg-scale for glucosylglycerol; 100 g-scale for cello-oligosaccharides; and milligram-scale for human milk oligosaccharides. Moreover, acib offers to develop fully new biocatalytic production routes for valuable prebiotics or to make current production processes more cost-efficient, by improved biocatalysts and better formulation, as well as through reaction and process engineering including integrated downstream processing (membrane filtration). acib transfers all necessary technology to the production partner ensuring a seamless transition to industrial-scale production. Intellectual property (IP) generated during the collaboration can be transferred to you, our investor/industrial partner. Tap into acib’s extensive 30-year history of industry experience and its track record of partnerships with more than 250 industry partners.
acib offers you the opportunity to establish with us cost-efficient high-purity bioproduction processes for valuable prebiotics.
Experts:
Prof. Dr. Bernd Nidetzky, Dr. Christiane Luley, Dr. Barbara PetschacherDevelopment status:
TRL 3-7 (i.e. from experimental proof-of-concept to demonstration in operational environment)IPR:
EP2332426A1EP2509450B1
